| Analysis | Samples | Factors | Units |
|---|---|---|---|
| HILIC UNSPECIFIED ION MODE | NN.007 | Treatment:Apalutamide_C13Glc | Abundance |
| HILIC UNSPECIFIED ION MODE | NN.008 | Treatment:Apalutamide_C13Glc | Abundance |
| HILIC UNSPECIFIED ION MODE | NN.009 | Treatment:Apalutamide_C13Glc | Abundance |
| HILIC UNSPECIFIED ION MODE | NN.019 | Treatment:Apalutamide_C13Gln | Abundance |
| HILIC UNSPECIFIED ION MODE | NN.020 | Treatment:Apalutamide_C13Gln | Abundance |
| HILIC UNSPECIFIED ION MODE | NN.021 | Treatment:Apalutamide_C13Gln | Abundance |
| HILIC UNSPECIFIED ION MODE | NN.010 | Treatment:ARCC4_C13Glc | Abundance |
| HILIC UNSPECIFIED ION MODE | NN.011 | Treatment:ARCC4_C13Glc | Abundance |
| HILIC UNSPECIFIED ION MODE | NN.012 | Treatment:ARCC4_C13Glc | Abundance |
| HILIC UNSPECIFIED ION MODE | NN.022 | Treatment:ARCC4_C13Gln | Abundance |
| HILIC UNSPECIFIED ION MODE | NN.023 | Treatment:ARCC4_C13Gln | Abundance |
| HILIC UNSPECIFIED ION MODE | NN.024 | Treatment:ARCC4_C13Gln | Abundance |
| HILIC UNSPECIFIED ION MODE | NN.004 | Treatment:Enzalutamide_C13Glc | Abundance |
| HILIC UNSPECIFIED ION MODE | NN.005 | Treatment:Enzalutamide_C13Glc | Abundance |
| HILIC UNSPECIFIED ION MODE | NN.006 | Treatment:Enzalutamide_C13Glc | Abundance |
| HILIC UNSPECIFIED ION MODE | NN.016 | Treatment:Enzalutamide_C13Gln | Abundance |
| HILIC UNSPECIFIED ION MODE | NN.017 | Treatment:Enzalutamide_C13Gln | Abundance |
| HILIC UNSPECIFIED ION MODE | NN.018 | Treatment:Enzalutamide_C13Gln | Abundance |
| HILIC UNSPECIFIED ION MODE | QC.blank1 | Treatment:NA | Abundance |
| HILIC UNSPECIFIED ION MODE | QC.blank2 | Treatment:NA | Abundance |
| HILIC UNSPECIFIED ION MODE | QC.blank3 | Treatment:NA | Abundance |
| HILIC UNSPECIFIED ION MODE | NN.001 | Treatment:Vehicle_C13Glc | Abundance |
| HILIC UNSPECIFIED ION MODE | NN.002 | Treatment:Vehicle_C13Glc | Abundance |
| HILIC UNSPECIFIED ION MODE | NN.003 | Treatment:Vehicle_C13Glc | Abundance |
| HILIC UNSPECIFIED ION MODE | NN.013 | Treatment:Vehicle_C13Gln | Abundance |
| HILIC UNSPECIFIED ION MODE | NN.014 | Treatment:Vehicle_C13Gln | Abundance |
| HILIC UNSPECIFIED ION MODE | NN.015 | Treatment:Vehicle_C13Gln | Abundance |
Return to study ST002865 main page
Download data matrix(Metabolic profiling, glucose tracing and glutamine tracing in 16D prostate cancer cells treated with vehicle, AR inhibitor Enzalutamide, AR inhibitor Apalutamide, or AR degrader/PROTAC ARCC-4 HILIC UNSPECIFIED ION MODE)
- Metabolomics Workbench
|